AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

Summary

RATIONALE: Monoclonal antibodies, such as AMG-479, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. PURPOSE: This phase I trial is studying the side effects and best dose of AMG-479 in treating patients with advanced solid tumors or non-Hodgkin lymphoma.

Timeline

Start

2005-10

Primary completion

2010-04

Completion

2010-06

Drugs

Indications